Laddar...
Nuclear EGFR Contributes to Acquired Resistance to Cetuximab
Epidermal growth factor receptor (EGFR) is a ubiquitously expressed receptor tyrosine kinase involved in the etiology of several human cancers. Cetuximab is an EGFR blocking-antibody that has been approved for the treatment of patients with cancers of the head and neck (HNSCC) and metastatic colorec...
Sparad:
| Huvudupphovsmän: | , , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
2009
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2900381/ https://ncbi.nlm.nih.gov/pubmed/19684613 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/onc.2009.234 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|